Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 8/20 | 0.61 |
| ▸ | KDM5C | P41229 | 6/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.61 |
| ▸ | KDM4A | O75164 | 5/20 | 0.61 |
| ▸ | KDM2A | Q9Y2K7 | 5/20 | 0.61 |
| ▸ | KDM3A | Q9Y4C1 | 5/20 | 0.61 |
| ▸ | KDM5B | Q9UGL1 | 5/20 | 0.61 |
| ▸ | KDM6B | O15054 | 4/20 | 0.61 |
| ▸ | KDM5A | P29375 | 3/20 | 0.61 |
| ▸ | KDM4D | Q6B0I6 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | TET3 | O43151 | 1/20 | 0.61 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | ASPH | Q12797 | 1/20 | 0.61 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.61 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.61 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.61 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.61 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30527973 | 1.00 | KDM4C (0.61) | KDM4CKDM5CKDM4EKDM4AKDM2A | |
| Hydrochloric Acid SCHEMBL29188716 | 0.98 | KDM4C (0.59) | KDM4CKDM5CKDM4EKDM4AKDM2A | |
| Formaldehyde SCHEMBL27828603 | 0.96 | KDM4C (0.57) | KDM4CKDM5CKDM4EKDM4AKDM2A | |
| Nitrous Acid SCHEMBL28404954 | 0.92 | KDM4C (0.53) | KDM4CKDM5CKDM4EKDM4AKDM2A | |
| SCHEMBL28786825 | 0.84 | LMNA (0.47) | KDM4CKDM5CKDM4EKDM4AKDM2A | |
| SCHEMBL25263407 | 0.83 | KDM1A (0.42) | KDM4CKDM5CKDM4EKDM4AKDM2A | |
| SCHEMBL2430356 | 0.81 | KDM1A (0.44) | KDM4CKDM5CKDM4EKDM4AKDM2A | |
| SCHEMBL3127472 | 0.81 | PARP1 (0.48) | KDM4CKDM5CKDM4EKDM4AKDM2A | |
| SCHEMBL1137138 | 0.81 | KDM1A (0.44) | KDM4CKDM5CKDM4EKDM4AKDM2A | |
| SCHEMBL31026889 | 0.81 | PARP1 (0.48) | KDM4CKDM5CKDM4EKDM4AKDM2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 846 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119753728-A | Preparation method of ordered defective indium cluster frame porous material for electrocatalytic conversion of carbon dioxide to urea | 东北师范大学 | 2025-04-04 | — | — | CN | claimed |
| CN-114555584-B | Ai Funi cloth (IVOSIDENIB) and process for producing intermediate thereof | 法国施维雅药厂 | 2024-07-05 | — | — | CN | claimed |
| CN-116854720-A | Isonicacid chelated aluminum oxide cluster compound, and macro preparation method and application thereof | 闽都创新实验室 | 2023-10-10 | — | — | CN | claimed |
| WO-2023131951-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | FORTEPHEST LTD. (IL) | 2023-07-13 | — | — | WO | claimed |
| WO-2023019912-A9 | BENZOTRIAZINE DIOXIDE AND PHARMACEUTICAL COMPOSITION THEREOF | 杭州瑞臻医药有限公司 | 2023-06-01 | — | — | WO | claimed |
| CN-115850244-B | Preparation method of topiroxostat | 成都大学 | 2023-05-16 | — | — | CN | claimed |
| CN-115850244-A | Preparation method of topiroxostat | 成都大学 | 2023-03-28 | — | — | CN | claimed |
| CN-115724793-A | Preparation method of 2-bromoisonicotinic acid nitrile | 山西永津集团有限公司 | 2023-03-03 | — | — | CN | claimed |
| WO-2023019912-A1 | BENZOTRIAZINE DIOXIDE AND PHARMACEUTICAL COMPOSITION THEREOF | 杭州瑞臻医药有限公司 | 2023-02-23 | — | — | WO | claimed |
| CN-114555584-A | Process for the preparation of ivonib (IVOSIDENIB) and intermediates thereof | 法国施维雅药厂 | 2022-05-27 | — | — | CN | claimed |
| EP-3364967-B1 | FERROPORTIN INHIBITORS | VIFOR INT AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025090928-A9 | COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | AQUINNAH PHARMACEUTICALS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026085629-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF | Université de Montréal (CA) | 2026-04-30 | — | — | WO | disclosed |
| EP-4709716-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | GENZYME CORPORATION (US) | 2026-03-18 | — | — | EP | disclosed |
| EP-4702025-A1 | BICYCLIC HETEROCYCLE COMPOUNDS FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2026-03-04 | — | — | EP | disclosed |
| US-4977267-A | ANTISECRETORY AGENT | FUJIREBIO KABUSHIKI KAISHA (JP) | 1990-12-11 | — | — | US | disclosed |
| US-4921867-A | Pyridine compounds useful for therapy or prophylaxis of a disease associated with airway obstruction | GLAXO GROUP LIMITED (GB) | 1990-05-01 | — | — | US | disclosed |
| US-4912101-A | Containing a secondary amide, suflur group and a furan ring | FUJIREBIO KABUSHIKI KAISHA (JP) | 1990-03-27 | — | — | US | disclosed |
| EP-0282077-A2 | Pyridyloxy derivatives | FUJIREBIO KABUSHIKI KAISHA (JP) | 1988-09-14 | — | — | EP | disclosed |
| EP-0278728-A2 | 1-(4-Amino-3,5-dichlorophenyl)-2-(substituted amino)ethanol derivatives and their use in the treatment of respiratory disease | GLAXO GROUP LIMITED (GB) | 1988-08-17 | — | — | EP | disclosed |